Bad Homburg vor der Höhe

Inovalis Real Estate Investment Trust Announces Financial Results for the Third Quarter Of 2021

Retrieved on: 
Wednesday, November 10, 2021
Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Finance, Construction & Property, REIT, Banking, European Globalisation Adjustment Fund for Displaced Workers, Q4, Joint venture, Courbevoie, Hôtel de Ville, Paris, Organization, CAD, Bad Homburg vor der Höhe, Angelo Gordon, Income, Exercise, IFRS, Program, Tenant, IP, Sale, Board, TSX, Trust, ESG, Trustee, Vaccination, REIT, FFO, Board of directors, Real estate, 3D printing, Lease, Property management

Inovalis Real Estate Investment Trust (the REIT) (TSX: INO.UN) today reported financial results for the quarter ended September 30, 2021.

Key Points: 
  • Inovalis Real Estate Investment Trust (the REIT) (TSX: INO.UN) today reported financial results for the quarter ended September 30, 2021.
  • Management remains confident in the strength of its portfolio, as indicated by Q3 2021 results and its strong rent collections, both in France and Germany.
  • The REIT is well positioned to opportunistically invest its substantial cash reserve in new assets as the real estate sector and European economy stabilizes.
  • Inovalis Real Estate Investment Trust is an unincorporated, open-ended real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario.

DGAP-News: Fresenius Medical Care AG & Co. KGaA reports results in line with expectations for the second quarter and confirms 2021 outlook

Retrieved on: 
Friday, July 30, 2021
Bad Homburg vor der Höhe, Fresenius, Germany, Health care

Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.

Key Points: 
  • Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.
  • Sustainability is an integral part of Fresenius Medical Care's mission and vision and is reflected in the corporate strategy.
  • These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

Retrieved on: 
Wednesday, July 28, 2021
Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Industry economics), Companies

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.

Key Points: 
  • BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.
  • Prior to joining Option Care Health, Dr. Kumbhat served as Senior Vice President and Regional Medical Officer for Fresenius Kabi.
  • As a physician, she brings a wealth of knowledge to the Option Care Health team, and Im confident she will make a positive impact in continuing efforts to elevate patient care, John Rademacher, Chief Executive Officer, commented.
  • Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

Fresenius Medical Care North America Announces New President for Renal Therapies Group

Retrieved on: 
Thursday, July 22, 2021
Bad Homburg vor der Höhe, Private providers of NHS services, Fresenius, Societates Europaeae, Germany, Health care, Diaverum

WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.

Key Points: 
  • WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.
  • Turk succeeds Mark Costanzo, who recently retired as President of FMCNA's Renal Therapies Group.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

UPS Healthcare Announces Agreement With Fresenius Medical Care, Expanding Service In The UK

Retrieved on: 
Thursday, July 22, 2021
Bad Homburg vor der Höhe, Private providers of NHS services, Fresenius, Societates Europaeae, Germany, Health care

Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.

Key Points: 
  • Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.
  • Wes Wheeler, President of UPS Healthcare, said, "UPS Healthcare is delighted to work with Fresenius Medical Care as a supply chain partner in the UK.
  • "One of the ongoing strategic priorities for Fresenius Medical Care is to constantly review and improve our operations," said Tim Wheeldon, Managing Director and Head of Fresenius Medical Care UK and Ireland.
  • Fresenius Medical Care UK has been caring for NHS kidney patients in the UK for over 20 years.

Ambulnz Launches Service in Illinois

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Clinical medicine, Health care, Membrane technology, Bad Homburg vor der Höhe, Detoxification, Dialysis, Renal dialysis, Fresenius, American Kidney Fund, Home hemodialysis

With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.

Key Points: 
  • With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.
  • Ambulnz will assist people getting to and from scheduled dialysis appointments.
  • Dialysis patients in Illinois using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.
  • Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Xenios AG receives approval in China for ECMO devices

Retrieved on: 
Tuesday, July 13, 2021
General Health, Health, Other Health, Bad Homburg vor der Höhe, Health care, Intensive care medicine, Medicine, Extracorporeal membrane oxygenation, Medical equipment, Membrane technology, Fresenius, Germany, Xenios AG, Fresenius Medical Care, XENIOS AG, FRESENIUS MEDICAL CARE

In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.

Key Points: 
  • In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.
  • As a result, a complete Xenios system is now permitted for ECMO therapy in China.
  • This Xenios ECMO complete system is certified in China for nine days application period.
  • The expedited approval was a joint effort by Xenios and Fresenius Medical Care China Team.

Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center

Retrieved on: 
Monday, June 28, 2021
Nursing, Education, Health, Hospitals, General Health, Other Education, Training, Bad Homburg vor der Höhe, Health care, Health, Private providers of NHS services, Fresenius, Health professional, Germany

Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.

Key Points: 
  • Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.
  • With the opening of the Training Center, Fresenius Medical Care Korea pledges its ongoing support of healthcare professional education.
  • The Fresenius Medical Care Training Center also offers educational opportunities catering to individual healthcare professionals specializing in particular treatment modalities such as PD, HD, and CRRT.
  • The Fresenius Medical Care Training Center will provide healthcare professionals with high-standard, systematic training, helping them to advance their knowledge and skills in renal and critical care.

Vifor Pharma to revise DIAMOND study, readout expected in H2 2021

Retrieved on: 
Thursday, June 24, 2021
Health, Clinical trials, Research, Science, Pharmaceutical, Cardiology, Biotechnology, Vifor Pharma, Bad Homburg vor der Höhe, Companies, Medical specialties, Health care, Fresenius, Hyperkalemia, Vifor Pharma Group, DIAMOND, hyperkalemia, VIFOR PHARMA GROUP, DIAMOND, HYPERKALEMIA

More than 1,000 patients with heart failure and with hyperkalemia or history of hyperkalemia have already been enrolled in DIAMOND.

Key Points: 
  • More than 1,000 patients with heart failure and with hyperkalemia or history of hyperkalemia have already been enrolled in DIAMOND.
  • Following the change of endpoints, study read-out and remaining data collection is expected to be completed in 2021.
  • Vifor Pharma will host a conference call today, 24 June 2021 at 10:30 am (CET).
  • Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care).

Fresenius Kabi Receives Premier Supplier Legacy Award

Retrieved on: 
Monday, June 21, 2021
Medical Supplies, Health, Fitness & Nutrition, General Health, Pharmaceutical, Biotechnology, Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Industry economics), Bidiphar

Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has received a 2021 Supplier Legacy Award from Premier Inc. ( www.premierinc.com ), a leading health care improvement company.

Key Points: 
  • Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has received a 2021 Supplier Legacy Award from Premier Inc. ( www.premierinc.com ), a leading health care improvement company.
  • Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and commitment to cost optimizations, according to Premier.
  • Thats why its particularly gratifying to receive this recognition from Premier, said John Ducker, president and CEO of Fresenius Kabi USA.
  • Legacy Award winners have a tenure of more than three years as a Premier contracted supplier.